Oxford spin-out OMass Therapeutics funding
The short answer
Oxford spin-out OMass Therapeutics has one funding round on record, totalling about $297M in disclosed capital. Its latest (Series C) was €275 million, reported 2026-10-16, with Jefferson Life Sciences named as investors.
- Disclosed total
- $297M
- Rounds logged
- 1
- Latest round
- Series C
- Sector
- Health
Every round on record
| Date | Amount | Round | Investors | Source |
|---|---|---|---|---|
| 2026-10-16 | €275 million | Series C | Jefferson Life Sciences | EU-Startups |
Other recent Health rounds
- Unravel Health€2.96 million · 2026-10-16
- Stride£4.6M · 2026-10-14
- Tracker: Suki$90M · 2026-10-14
- Allswell$7M · 2026-10-14
- Readily$11M · 2026-10-14
- PharmaTomatoUndisclosed · 2026-10-13
- Scarlet$50M · 2026-10-12
- General Medicine$120M · 2026-10-11
How this is measured
Rounds are logged from public announcements and the outlet credited in the source column. Amounts are as reported; nothing is estimated. If a figure is wrong or a round is missing, send it via the corrections page.